Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
Update: 2025-01-30
Description
Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.
Related Content:
Comments
In Channel




